Skip to main content
. Author manuscript; available in PMC: 2014 Apr 15.
Published in final edited form as: Cancer Res. 2013 Feb 19;73(8):2435–2444. doi: 10.1158/0008-5472.CAN-12-3381

Table 1.

Patient characteristics HCC (n=23) Normal Healthy (n=20)
Gender (M:F) 16:7 10:10

Median age (yrs) 64 (40–82)

Child Pugh Class Liver function A = 16
B = 7
C = 0

BCLC class A = 0
B = 21
C = 2
D = 0

Etiology of liver disease Hepatitis B = 1
Hepatitis C = 13
Hepatitis B and C = 1
Alcohol = 2
No known risk factor = 6

Prior therapies (some patients had more than one therapy hence numbers ≠ 23) None = 10
Locoregional = 8
Chemotherapy or biologic therapy = 7
Liver resection = 4

For the stimulation assays 8 patients were chosen. Of those patients 5 are alive, median follow up time is 15 months (range 12–25 months) and of the 3 patients who have died, median survival was 7 months (range 2–10 months). The patients had BCLC class B (n=7) or C (n=1) liver function and Child Pugh class A (n=6) or class B (n=2) liver function. The etiology of cirrhosis was chronic hepatitis C (n=4) and neither hepatitis HBV or HCV (n=4).